2月24日A股投資避雷針︱瀚微股東:朗瀚公司擬減持不超過2%股份;華是科技:實控人之一、董事、總經理葉建標被實施留置及立案調查
永冠新材股東謝秉政擬減持不超3%股份;富瀚微股東朗瀚公司擬減持不超過2%股份;英方軟件一致行動人好望角啓航、好望角越航、好望角葦航擬合計減持不超3%股份;福萊新材尚未接到機器人電子皮膚方面的訂單;泰豪科技公司相關產品目前銷售數量及盈利水平的影響較小;趣睡科技目前並未在人形機器人零部件領域有相應的業務;江蘇雷利人形機器人零部件產品仍處於研發和送樣測試階段;華是科技實控人之一、董事、總經理葉建標被實施留置及立案調查

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.